Eagle Vision Pharmaceutical eaglevpc.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1148)

Eagle Vision Pharmaceutical Corporation - The Eagle Vision SeeMoreTM imaging agent is a of its kind to harness the power of MRI to provide results in three critical areas: cardiac perfusion, cardiac function and cardiac vessel status, which today require multiple tests that cost thousands of dollars. The metabolic imaging agent based on manganese uptake is being tested in phase II clinical studies. In addition, the company has preclinical data for its use in solid tumor imaging in breast cancer...Show all

Eagle Vision Pharmaceutical Corporation - The Eagle Vision SeeMoreTM imaging agent is a of its kind to harness the power of MRI to provide results in three critical areas: cardiac perfusion, cardiac function and cardiac vessel status, which today req...Show all

Company (Alive / Active)

Phone: 610-363-6928

Fax:

50 West Welsh Pool Road
Exton, 19341
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Eagle Vision Pharmaceutical $0.3M Apr 18, 2003
See all 12 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Eagle Vision Pharmaceutical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Intarcia Therapeutics

Boston, Massachusetts, United States
Alive / ActiveIntarcia Therapeutics is a biopharmaceutical company based in Bostom, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to delive...Show allLogin to see details

Corthera

San Mateo, California, United States
AcquiredCorthera Inc. is a private biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for the treatment of acute heart failure. The company has worldwide rights to develop and commercialize relaxin. For more information, visit www.corthera.com. Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodil...Show allLogin to see details
See all 12 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)